The Process Development Blog

Subtle changes in particle size, shape, & distribution can have a major impact on pharma solubility and stability and cause flow and formulation issues.

At APC, we’re very proud of the fact that we help companies accelerate the development of therapeutics for rare diseases.

[WEBINAR] Good crystallization process design, can save months of development time. But, crystallization of stereoisomers can be particularly challenging.

[WEBINAR] In this webinar, we share methods to screen and optimize reactions under extreme time constraints using flow chemistry setups integrated with PAT.

Predicting the percolation threshold, using statistical models or experimentation, is an evidence-based approach that can get solid dosage forms designed faster.

[WEBINAR] Traditional solvent screening takes too long to fix issues for fast-moving clinical candidates. But modeling & smart experiments speed things up.

Computational methods play an increasingly important role in all stages of drug development and when used judiciously can help accelerate the timelines required to get over various process and manufacturing hurdles.

APC welcomed Irish Prime Minister to discuss fast-tracking a COVID-19 vaccine with Australian firm Vaxine, showcasing our role in advancing vital medicines.

APC’s CEO Dr Mark Barrett, discusses Ireland’s involvement in the pharmaceutical industry and APC’s current plans on developing a COVID-19 vaccine in partnership with Vaxine Pty Ltd.

Irish R&D firm APC partners with Australian biotech Vaxine to speed up COVID-19 vaccine candidate development, accelerating the time to patients.